ClinicalTrials.gg
RecruitingNCT07603973OA-AIDUpdated May 22, 2026

Effect of an Information- and Self-management App for People With Knee Osteoarthritis

An interventional study of Information- and self-management app and Control in Knee Osteoarthritis, sponsored by Diakonhjemmet Hospital. Recruiting at 1 site in Norway. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.

Sponsored by Diakonhjemmet Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year later.
Phase
Not applicable
Study type
Interventional
Enrollment
204
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

The primary aim of the trial is to assess if an information- and self-management app provided in the period between referral and consultation in specialist healthcare can improve knowledge about osteoarthritis and decision quality during consultation in patients with knee osteoarthritis.

204 patients will be randomized to either being on the waiting list for consultation, accessing publically available information about osteoarthritis (control group) or getting access to an 8-week information- and self-management intervention delivered through the Genus app prior to consultation.

Pasients with answer questionnaires at baseline, 4 weeks (intervention group only), 8 weeks, post consultation and 1 and 2 years after consultation.

The Genus app contains information videos, exercise videos, quizzes, feedback and questionnaires provided in a progressive order over an 8 week period.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • knee osteoarthritis
  • digital support tool
  • app
  • evidence-based treatment
  • information
  • self-management
03

In context

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

This study's planned enrollment of 204 is above the median of 68 across 2,714 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Diakonhjemmet Hospital is the lead sponsor of 62 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women > 50 years referred to specialist healthcare for knee OA management

Exclusion criteria

Exclusion Criteria:

  • Received joint replacement or are under consideration for revision in the referred joint
  • Have undergone joint replacement surgery in opposite knee
  • Have uncontrolled serious comorbidities
  • Have cognitive deficits
  • Are seeking care for recent knee trauma conditions (less than 6 months after trauma) or mainly psoriatic/rheumatoid arthritis
  • Unable to understand Norwegian
  • Do not possess a smartphone
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
204 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Getting access to an information- and self-management app in the waiting period from referral to consultation in specialist healthcare

    Device: Information- and self-management app

  • Active comparator
    Control group

    Getting access to publicly available information in the waiting period from referral to consultation in specialist healthcare

    Other: Control

Interventions

  • DeviceInformation- and self-management app

    An information- and self-management intervention delivered through the Genus app, including information videos, exercise videos, questionnaires, quizzes and feedback provided over an 8 week period prior to consultation in specialist healthcare

  • OtherControl

    Information on where to access publically available information about knee osteoarthritis

06

What researchers measure

Primary outcomes

  1. Knee Osteoathritis Knowlegde Scale (KOAKS)

    11 statements about osteoarthritis and treatment options, answered on a 5-point scale from 1 (=true) to 5 (=not true), summed up to a scale from 11 to 55

    Time frame: Baseline, 8 weeks, approx. 2-4 months after baseline (1 day after consultation (post consultation))

  2. Decision Conflict Scale (DCS)

    16 statements with 5 response categories about the patients uncertainty with treatment options. The total score range from 0 (no decisional conflict) to 100 (extreme decisional conflict). The DCS also has five subscales (all 0-100): 1) uncertainty, 2) informed, 3) values clarity, 4) support, and 5) effective decision.

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

Secondary outcomes

  1. Concordance between preferences and treatment decision

    Measured with one qustion form the Decision Conflict Scale (DSC), 5 response options.

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

  2. Decisional quality

    Measured with section 3 (decision process scale) in the Decision Quality Index for Knee Osteoarthritis (K-DQI) which consists of 5 questions. Four of these questions are summed to a 0-4 score with higher score indicating more shared decision-making.

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

  3. Level of shared decision-making

    Mesured with the CollaboRATE questionnaire, comprising 3 questions measured on a 0-9 scale, with a higher score indicating better experience. Scores are calculated using the top score method indicating the percentage of patients scoring top score for all three questions, or

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

  4. Satisfaction with treatment choice

    Measured on a numeric rating scale (0-10, with higher score indicating more satisfaction)

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

Other outcomes

  1. Motivation for exercise

    Measured on a numeric rating scale from 0 to 10 with higher score indicating higher motivation

    Time frame: Baseline, 4 weeks (only intervention group), 8 weeks

  2. Motivation for surgery

    Measured on a numeric rating scale from 0 to 10 with higher score indicating higher motivation

    Time frame: Baseline, 4 weeks (only intervention group), 8 weeks

  3. Assessment of knee-related pain

    Measured with the Knee Injury and Osteoarthritis Outcome Score (pain section), comprising 9 questions scored on a 5-point scale and calculated to a 0-100 score with higher score indicating less pain

    Time frame: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years

  4. Assessment of knee-related function

    Measured with the Knee Injury and Osteoarthritis Outcome Score (function section), comprising 17 questions scored on a 5-point scale and calculated to a 0-100 score with higher score indicating less pain

    Time frame: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years

  5. Assessment of knee-related quality of life

    Measured with the Knee Injury and Osteoarthritis Outcome Score (quality of life section), comprising 4 questions scored on a 5-point scale and calculated to a 0-100 score with higher score indicating less pain

    Time frame: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years

  6. Health-related quality of life

    Mesured with EQ-5D-5L, comprising 5 questions with 5 response options. Summed to an utility index from 1 to 0, with 1 being best health-related quality of life. Additionally a visual analog scale from 0 to 100 with 100 indicating best health.

    Time frame: Baseline, 1 and 2 years

  7. Level of shared decision-making therapist

    Measured with 7 statements from the MAPPIN'SDM Therapist, measured on a 5-point scale

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

  8. Preferred decision-making role

    Measured with the Control Preference Scale, comprising a question with 5 statements about roles, corresponding to active role, collaborative role and passive role

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

  9. Illness perception

    Measured with the Brief Illness Perception Questionnaire (B-IPQ) comprising 8 questions scored on a 0-10 scale, summed to a 0 to 80 score with higher score indicating poorer illness perception

    Time frame: Baseline, 8 weeks

  10. Pain self-efficacy

    Measured with the Pain Self-Efficacy Questionnaire (PSEQ-2) comprising 2 questions about pain self-efficacy, answered on a 0 (not at all confident) to 6 (completely confident) scale.

    Time frame: Baseline, 8 weeks

  11. Pain catastrophizing

    Measured with one question about consern about pain, measured on a 0 (not at all) to 4 (all the time) scale.

    Time frame: Baseline, 8 weeks

  12. Pain intensity

    Measured with four questions from the Brief Pain Inventory, assessed on numeric rating scales from 0 (no pain) to 10 (worst possible pain).

    Time frame: Baseline, 8 weeks

  13. Pain intensity now

    Measured with one question about pain intensity now on a numeric rating scale from 0 (no pain) to 10 (worst possible pain).

    Time frame: Baseline, 4 weeks (only intervention group), 8 weeks, 1 and 2 years

  14. Disease activity

    Measured with a numeric rating scale from 0 (no disease activity) to 10 (worst disease activity)

    Time frame: Baseline, 8 weeks, 1 and 2 years

  15. Fatigue

    Measured on a numeric rating scale from 0 (no fatigue) to 10 (worst possible fatigue)

    Time frame: Baseline, 8 weeks, 1 and 2 years

  16. Importance of treatment options

    Measured with five questions from Dicision Quality Index for Knee Osteoarthritis (section 1). Assessed on numeric rating scales from 0 (not at all important) to 10 (extremely important)

    Time frame: Baseline, 8 weeks

  17. Preferred treatment

    Measured with a question about if they prefer surgery or non-surgical treatment

    Time frame: Baseline, 8 weeks

  18. Health literacy

    Measured with the HLS19-Q12 comprising 12 questions about health literacy answered on a 4-point likert scale from 1 (very difficult) to 4 (very easy). Calculated as percentage (0-100) of items with valid responses that were answered with very easy or easy

    Time frame: Baseline

  19. Self-efficacy of digital solutions

    Measured with six questions about the self-efficacy of using different digital solutions (mobile phone, tablet, computer, apps, identification portal, helsenorge.no), assessed on a 6-point scale from never tried to manage very well

    Time frame: Baseline

  20. Previous treatment

    Assessment of previous treatment, answered with yes/no on questions related to previous physiotherapy treatment, previous osteoarthritis school,

    Time frame: Baseline

  21. Health problems impact on daily living

    Measured with one question from the Work Productivity and Activity Impairment questionnaire (WPAI) (question 6), anwered on a numeric rating scale from 0 (no effect on daily activities) to 10 (completely prevent from doing daily activities)

    Time frame: Baseline, 8 weeks, 1 and 2 years

  22. Decision regret

    Measured with item 2 from the Decision regret scale, answered on a 5-point scale from totally agree to totally disagree

    Time frame: approx. 2-4 months after baseline (1 day after consultation (post consultation))

  23. Use of pain medication

    Assessed with an open-ended question about the use of pain medication last three months (type and dosage)

    Time frame: Baseline, 8 weeks, 1 and 2 years

  24. Demographics

    Measured with questions about gender, age, education level, working status, smoking, living arrangements, sosioeconomic status, and support

    Time frame: Baseline

  25. Antropometrics

    Measured as self-reported hight and weight

    Time frame: Baseline

  26. Joint-spesific information

    Measured with questions about most trouble some knee, duration of complaints, other joints with complaints

    Time frame: Baseline

  27. Exercise level

    Measured with one question about exercise level answered on a 5-point scale from do not exercise to exercise 3 or more times per week

    Time frame: Baseline, 8 weeks, 1 and 2 years

  28. Comorbidities

    Assessed with 15 questions about the presens of different diseases (yes/no)

    Time frame: Baseline

  29. Usability of the app

    Measured with System Usability Scale (SUS) comprising 10 statements answered on a 5-point scale from strongly disagree to strongly agree, converted to a 0 to 100 score with higher score indicating better usability

    Time frame: 8 weeks (only intervention group)

  30. Satisfaction with the app

    Measured with two questions about the satisfaction with the information videos and exercise videos in the app, answered on numeric rating scales from 0 (not statisfied) to 10 (very satisfied)

    Time frame: 8 weeks (only the intervention group)

  31. Suitability of the app

    Measured with two questions about the suitability of providing information and exercises through an app, answered on numeric rating scales from 0 (not suitable) to 10 (very suitable)

    Time frame: 8 weeks (only the intervention group)

  32. Surgical treatment

    Measured with a question about whether the patient has undergone surgical treatment (yes/no) and for those answering yes; five questions about the improvement/satisfaction with the surgical treatment, measured on a 5-point scale from very satisfied to very dissatisfied

    Time frame: 1 and 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — IPD will not be shared due to GDPR regulations

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07603973
Lead sponsor
Diakonhjemmet Hospital
Responsible party
Anne Therese Tveter (Professor, Diakonhjemmet Hospital) — Principal investigator
First posted
May 22, 2026
Start date
Oct 30, 2025
Primary completion
Oct 1, 2028 (estimated)
Completion
Dec 31, 2035 (estimated)
Last update
May 22, 2026

Study contacts

Anne Therese Tveter, PhD
Contact
a.t.tveter@medisin.uio.no
+4791115550

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion